West Cancer Center and Research Institute

Germantown, Tennessee 38138

1 studies enrolling now · 5 studies all time

What they study most

Advanced Melanoma, Advanced Solid Tumor, Locally Advanced Solid Tumors, Lymphoma, Metastatic Solid Tumors, Solid Tumor, Solid Tumor, Adult

Studies at this site

• VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] — Recruiting now
• A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) — Running, not enrolling
• TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers — Completed
• TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers — Completed
• This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. — Stopped early